Menu

Report Library

All Reports

Citeline 2015 Pharma R&D Annual Review Report

February 17, 2015

Welcome to Citeline’s 2015 review of trends in pharmaceutical R&D. For around a quarter of a century, Citeline's Ian Lloyd has taken an annual look at the state of the pharma R&D universe, and compared it to similar data gathered over the many years using Citeline's Pharmaprojects platform.

In this article, Lloyd looks at how pipeline as a whole has changed in the past twelve months and finds indicators of what the new year might bring. Keep an eye out for Citeline's review of 2014’s New Active Substance launches which will serve as a supplement to this report and scheduled to be released at the beginning of March 2015.

In addition, an infographic highlighting key data from the report has also been published.

To download the report, click the PDF link at the top of the page.

For more information about Citeline, or to view their other white paper reports, please visit Citeline here.
Disease Group Covered: Allergy
Autoimmune/immunology
Cardiovascular
Dermatology
Endocrine
ENT/Dental
Gastroenterology (Non Inflammatory Bowel Disease)
Hematology
Infectious Disease
Metabolic
Neurology
Not Specified
Obstetrics/Gynecology
Oncology
Ophthalmology
Orthopedics
Psychiatry
Renal
Respiratory
Rheumatology (Non Autoimmune)
Urology